Skip to main content
. 2022 Nov 28;12:20495. doi: 10.1038/s41598-022-23319-1

Figure 2.

Figure 2

Landscape of studies reporting the prevalence of dMMR/MSI/high TMB. (a) Number of studies by cancer stage; (b) the relative proportion of studies by cancer stage; (c) the relative proportion of studies by study sample size; (d) the relative proportion of studies by tumour group; (e) number of studies reporting the prevalence of dMMR/MSI; and (f) number of studies reporting the prevalence of high TMB. dMMR mismatch repair deficiency; MSI microsatellite instability; TMB tumour mutational burden.